Drug intelligence / Profile preview

phenylephrine + heparin

Development stage
Unknown
Lead developer
Talphera
Modality
Small Molecules
Administration
Intravenous, Topical
01

Overview

Phenylephrine + heparin is a combination of two active pharmaceutical ingredients used together, typically in hospital or procedural settings. Phenylephrine is an alpha-1 adrenergic receptor agonist that acts as a vasoconstrictor, increasing blood pressure and reducing swelling by constricting blood vessels[3][8]. Heparin is an anticoagulant that prevents the formation and extension of blood clots by potentiating the activity of antithrombin III, thereby inhibiting thrombin and factor Xa[6]. This combination may be used in clinical scenarios where both vasoconstriction (to maintain vascular tone or reduce local bleeding) and anticoagulation (to prevent catheter-related thrombosis or maintain line patency) are desired. There are no widely recognized brand names for this specific combination; it may be prepared for specific procedural use.

02

Targets

ADRA1A (α1A)ATIII (Antithrombin III)

Beyond the preview

Go deeper on phenylephrine + heparin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phenylephrine + heparin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call